Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Dicerna Pharmaceuticals, Inc. (DRNA)

« Back to company index

DRNA Chatter Timeline

Stock Ticker for DRNA

Most Active Tweeters for DRNA

UserTweets
@gcassidy718 6
@TheMarketsDaily 4
@macondailynews 3
@BlueBioNow 3
@StockTexts 2

Recent Tweets for DRNA

InsiderAlertsIA @InsiderAlertsIA
$DRNA: New Insider Filing on EVP & Chief Operating Officer JAMES B WEISSMAN: https://t.co/mSZ36cQLlY
October 21st 2019, 8:10am
dispatchtribune @dispatchtribune
Dicerna Pharmaceuticals $DRNA Raised to “Buy” at BidaskClub https://t.co/hprpKUjGbz
October 21st 2019, 7:10am
gcassidy718 @gcassidy718
$DRNA holding until $18.03 dollars a share https://t.co/og81erSpQm
October 20th 2019, 1:10pm
TheMarketsDaily @TheMarketsDaily
Dicerna Pharmaceuticals $DRNA Rating Increased to Buy at BidaskClub https://t.co/seVTTMC2r9
October 20th 2019, 9:10am
registrarjourn @registrarjourn
Dicerna Pharmaceuticals $DRNA Raised to “Buy” at BidaskClub https://t.co/MqXneaAyTh
October 20th 2019, 9:10am
EnterpriseLeade @EnterpriseLeade
Dicerna Pharmaceuticals $DRNA Raised to “Buy” at BidaskClub https://t.co/EDFXNWtxug
October 20th 2019, 9:10am
the_chart_life @the_chart_life
$DRNA Dicerna Pharma ..."Focuses on the discovery and development of ribonucleic acid interference (RNAi)-based pha… https://t.co/rjniQjm75d
October 20th 2019, 12:10am
TickerReport @TickerReport
Dicerna Pharmaceuticals $DRNA Rating Increased to Buy at BidaskClub https://t.co/U1NRvp4d1o
October 19th 2019, 4:10pm
BlueBioNow @BlueBioNow
$DRNA blockbuster 3.73 % change recently https://t.co/6L4jysCGvR
October 19th 2019, 1:10pm
dailypoliticaln @dailypoliticaln
Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/xtWLkkp2t4
October 19th 2019, 11:10am
ZolmaxNews @ZolmaxNews
Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/PlTkwhtYnd
October 19th 2019, 11:10am
ThisLincolnian @ThisLincolnian
Dicerna Pharmaceuticals $DRNA Trading 5.4% Higher https://t.co/jFkwHqnoyt
October 19th 2019, 10:10am
StockTexts @StockTexts
$DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/3dUWZrSNAI
October 19th 2019, 9:10am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $DRNA? The Short Ratio is 11.21% https://t.co/cK96TdziHl
October 18th 2019, 10:10pm
StockTexts @StockTexts
$DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/3dUWZsaoZi
October 18th 2019, 7:10pm
confcalltran @confcalltran
Dicerna Pharmaceuticals's EVP %26 Chief Operating Officer just picked up 4,904 shares https://t.co/30NOk4oTva $DRNA
October 18th 2019, 7:10pm
Jon12508683 @Jon12508683
$drna, nice weekly candle. per last cc, "We look forward to announcing proof-of-concept data for DCR-HBVS in the fi… https://t.co/X4VVGSfutM
October 18th 2019, 5:10pm
1111DLH61 @1111DLH61
$DRNA getting very extended here
October 18th 2019, 3:10pm
TranscriptDaily @TranscriptDaily
BidaskClub Upgrades Dicerna Pharmaceuticals $DRNA to Buy https://t.co/SP71KDGRrD
October 18th 2019, 10:10am
stocknewstimes @stocknewstimes
BidaskClub Upgrades Dicerna Pharmaceuticals $DRNA to Buy https://t.co/dofAUqA4hu
October 18th 2019, 10:10am
TheMarketsDaily @TheMarketsDaily
Dicerna Pharmaceuticals $DRNA Trading 5.4% Higher https://t.co/t7w4ucROZ9
October 17th 2019, 8:10pm
macondailynews @macondailynews
Dicerna Pharmaceuticals $DRNA Trading 5.4% Higher https://t.co/f4apSXSVJY
October 17th 2019, 8:10pm
BlueBioNow @BlueBioNow
$DRNA what a Company 3.27 % change recently https://t.co/6L4jysCGvR
October 17th 2019, 3:10pm
dispatchtribune @dispatchtribune
Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by Zacks Investment Research https://t.co/1K7sfNvhRI
October 17th 2019, 4:10am
ThisLincolnian @ThisLincolnian
Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by Zacks Investment Research https://t.co/m1yEhscYTa
October 17th 2019, 4:10am
BlueBioNow @BlueBioNow
$DRNA might be worth taking a position when this bottoms 2.76 % change recently https://t.co/6L4jysCGvR
October 16th 2019, 12:10am
OlympiaReport @OlympiaReport
Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/zjXBbQ54bq
October 15th 2019, 11:10pm
WeekHerald @WeekHerald
Zacks Investment Research Downgrades Dicerna Pharmaceuticals $DRNA to Sell https://t.co/zx2RqhPAMe
October 15th 2019, 11:10pm
gcassidy718 @gcassidy718
$DRNA here we go!! 2.29 % change recently https://t.co/og81erSpQm
October 14th 2019, 3:10pm
gcassidy718 @gcassidy718
$DRNA holding until $16.34 dollars a share https://t.co/og81erSpQm
October 13th 2019, 2:10pm
TheMarketsDaily @TheMarketsDaily
Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Quarterly Sales of $11.70 Million https://t.co/YmIZLxenLC
October 12th 2019, 9:10pm
dakotafinancial @dakotafinancial
$11.70 Million in Sales Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/n6LNQYTDw4
October 12th 2019, 9:10pm
gcassidy718 @gcassidy718
$DRNA holding until $16.34 dollars a share https://t.co/og81erAOYO
October 12th 2019, 3:10pm
macondailynews @macondailynews
Zacks: Brokerages Expect Dicerna Pharmaceuticals Inc $DRNA to Announce -$0.29 Earnings Per Share https://t.co/qVe2k79EYz
October 11th 2019, 3:10pm
TheMarketsDaily @TheMarketsDaily
Zacks: Analysts Expect Dicerna Pharmaceuticals Inc $DRNA Will Announce Earnings of -$0.29 Per Share https://t.co/4VahWGn2Y9
October 11th 2019, 3:10pm
gcassidy718 @gcassidy718
$DRNA holding until $15.75 dollars a share https://t.co/og81erSpQm
October 9th 2019, 1:10pm
dakotafinancial @dakotafinancial
-$0.29 Earnings Per Share Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/ztE0RKDiZF
October 9th 2019, 9:10am
macondailynews @macondailynews
Dicerna Pharmaceuticals Inc $DRNA Expected to Post Quarterly Sales of $11.70 Million https://t.co/HjjZxmvJzi
October 9th 2019, 9:10am
gcassidy718 @gcassidy718
$DRNA might be worth taking a position when this bottoms -3.32 % change recently https://t.co/og81erSpQm
October 8th 2019, 6:10pm
DataTrials @DataTrials
$DRNA Phase 2 A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyp… https://t.co/9SObYcvEMK
October 8th 2019, 7:10am
WeekHerald @WeekHerald
Analyzing Dicerna Pharmaceuticals $DRNA & Aimmune Therapeutics $AIMT https://t.co/oovNYS3BI9
October 8th 2019, 4:10am
RNAiAnalyst @RNAiAnalyst
Comparison of $ABUS and $DRNA HBV RNAi agents in AAV mouse model: https://t.co/QZPrpNECiV
October 7th 2019, 4:10pm
mikegoodma @mikegoodma
$DRNA at Chardan conf. FDA said redux urinary oxalate alone is an approvable endpoint for PH1. Fambrough confident… https://t.co/wvtZLEEa4P
October 7th 2019, 2:10pm
AmericanBanking @AmericanBanking
Brokerages Expect Dicerna Pharmaceuticals Inc $DRNA Will Post Quarterly Sales of $11.70 Million https://t.co/sVA7i7yn53 #stocks
October 6th 2019, 12:10pm
dailypoliticaln @dailypoliticaln
Brokerages Set Dicerna Pharmaceuticals Inc $DRNA PT at $23.00 https://t.co/jEasfU63hY
October 5th 2019, 10:10am
macondailynews @macondailynews
Dicerna Pharmaceuticals Inc $DRNA Receives Consensus Rating of “Buy” from Analysts https://t.co/vkzHNeyxg0
October 5th 2019, 10:10am
battagliame30 @battagliame30
@_Superbrat_ @JPZaragoza1 Is $VIR deciding not to go after Protein-X(HBX) like $DRNA. Guess all these questions hav… https://t.co/PTdLtgESHC
October 5th 2019, 12:10am
SeekingAlpha @SeekingAlpha
$DRNA - Dicerna Pharmaceuticals (DRNA) Presents At Cantor Healthcare Conference - Slideshow. Read more and get upda… https://t.co/3Qiw7zmI38
October 4th 2019, 2:10pm
mikegoodma @mikegoodma
$DRNA's only remaining proprietary undisclosed asset is for a large-population disease. It entered the pipeline lat… https://t.co/sxoURZWUpL
October 4th 2019, 2:10pm
AmericanBanking @AmericanBanking
-$0.29 Earnings Per Share Expected for Dicerna Pharmaceuticals Inc $DRNA This Quarter https://t.co/6sW5uMGYGF #stocks
October 4th 2019, 1:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.